Louis Gerstner Elected Chairman of Broad Institute Board of Directors

  Louis Gerstner Elected Chairman of Broad Institute Board of Directors

  Former IBM chairman and CEO brings deep expertise in business, leadership

Business Wire

CAMBRIDGE, Mass. -- January 22, 2013

The Broad Institute today announced that renowned business leader Louis V.
Gerstner, Jr. will become the next chairman of the Broad Institute’s Board of
Directors. Mr. Gerstner served as CEO and chairman of the board of IBM
Corporation from 1993 to 2002. He is widely recognized as the chief architect
of the company’s transformation, reinventing both its organization and its

Mr. Gerstner succeeds outgoing Broad Institute chair Diana Chapman Walsh, who
will continue to serve on the board, assuming the role of vice chair.

“Lou is an extraordinary leader and I am thrilled that he will be leading our
board,” said Broad Institute Director and President Eric Lander. “I am also
deeply grateful to Diana for her exceptional service as our inaugural board
chair. Her extraordinary leadership has been crucial to the success of the
Broad Institute.”

Following his leadership of IBM, Mr. Gerstner served as chairman of The
Carlyle Group. Prior to joining IBM, he was chairman and CEO of RJR Nabisco,

The Broad Institute’s Board of Directors brings together world-class leaders
from science, law, education and business. These distinguished individuals
serve as wise and effective stewards of the institute, helping to drive the
transformation of medicine that lies at the heart of the institute’s mission.
Mr. Gerstner was elected to the Broad Institute board in 2010.

“The Broad is at the forefront of truly remarkable advances in the world of
biomedical research, technology and innovation,” said Mr. Gerstner. “It is an
amazing organization and I look forward to serving in this new role.”

In addition to his significant business achievements, Mr. Gerstner has also
been a tireless advocate of improving K-12 education in the U.S., launching
initiatives aimed at setting high academic standards and improving teacher and
student performance.

“This is a time of breathtaking possibility for genomic medicine and it is a
joy to support the Broad Institute’s brilliant investigators as they create a
new future,” said outgoing Broad Institute chair Diana Chapman Walsh. “I look
forward with pleasure to Lou’s leadership and to working with him to continue
enabling an exceptional board to bring its very best to a truly unique

About the Broad Institute of MIT and Harvard
The Eli and Edythe L. Broad Institute of MIT and Harvard was founded in 2003
to empower this generation of creative scientists to transform medicine with
new genome-based knowledge. The Broad Institute seeks to describe all the
molecular components of life and their connections; discover the molecular
basis of major human diseases; develop effective new approaches to diagnostics
and therapeutics; and disseminate discoveries, tools, methods and data openly
to the entire scientific community.

Founded by MIT, Harvard and its affiliated hospitals, and the visionary Los
Angeles philanthropists Eli and Edythe L. Broad, the Broad Institute includes
faculty, professional staff and students from throughout the MIT and Harvard
biomedical research communities and beyond, with collaborations spanning over
a hundred private and public institutions in more than 40 countries worldwide.
For further information about the Broad Institute, go to


Broad Institute of MIT and Harvard
Nicole Davis, 617-714-7152
Press spacebar to pause and continue. Press esc to stop.